Search

Search Results

• UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

  José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano

  e2024065

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.065

  3890

  Suppl. Files: 1104

  PDF: 1061

  Html: 170

• EBV AND HHV-6 CIRCULATING SUBTYPES IN PEOPLE LIVING WITH HIV IN BURKINA FASO, IMPACT ON CD4 T CELL COUNT AND HIV VIRAL LOAD

  Lassina TRAORE, Ouéogo NIKIEMA, Abdoul Karim OUATTARA, Tegwindé Rébéca COMPAORE, Serge Théophile SOUBEIGA, Birama DIARRA, Dorcas OBIRI-YEBOAH, Pegdwendé Abel SORGHO, Florencia Wendkuuni DJIGMA, Cyrille BISSEYE, Albert Théophane YONLI, Jacques SIMPORE

  e2017049

  2017-09-01

  https://doi.org/10.4084/mjhid.2017.049

  3275

  PDF: 1262

  HTML: 898

• USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

  Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet

  e2010003

  2010-03-26

  https://doi.org/10.4084/mjhid.2010.003

  1079

  PDF: 513

  HTML: 821

• EPSTEIN-BARR VIRUS RELATED LYMPHOPROLIFERATIONS AFTER STEM CELL TRANSPLANTATION

  Simona Sica, Elisabetta Metafuni, Silvia Bellesi, Patrizia Chiusolo

  e2009019

  2009-12-14

  https://doi.org/10.4084/mjhid.2009.019

  1317

  PDF: 564

  HTML: 2983

• CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Rafael de la Camara

  e2016031

  2016-06-20

  https://doi.org/10.4084/mjhid.2016.031

  4783

  PDF: 1776

  HTML: 2704

  Untitled: 213

• CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

  Athanasios Aessopos, Vasilios Berdoukas

  e2009002

  2009-07-18

  1568

  PDF: 481

  HTML: 1435

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4231

  PDF: 1514

  HTML: 444

• PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

  Suparno Chakrabarti, Somnath Mukherjee

  e2009017

  2009-12-10

  https://doi.org/10.4084/mjhid.2009.017

  795

  PDF: 560

  HTML: 2456

• HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

  Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi

  e2009016

  https://doi.org/10.4084/mjhid.2009.016

  966

  PDF: 531

  HTML: 720

• The PARTIAL ACHIEVEMENT OF THE 90-90-90 UNAIDS TARGET IN A COHORT OF HIV INFECTED PATIENTS FROM CENTRAL ITALY.

  Elisabetta Schiaroli

  e2020017

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.017

  1496

  PDF: 770

  HTML: 206

• PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

  Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus

  e2014053

  2014-07-04

  https://doi.org/10.4084/mjhid.2014.053

  3295

  PDF: 1958

  HTML: 7472

• CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

  Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano

  e2020042

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.042

  1409

  PDF: 926

  HTML: 320

• MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

  Alfredo Marzano

  e2009025

  https://doi.org/10.4084/mjhid.2009.025

  833

  PDF: 486

  HTML: 1302

• PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA

  Roberto Stasi, Lian Wea Chia, Pallavi Kalkur, Robert Lown, Muriel S. Shannon

  e2009023

  https://doi.org/10.4084/mjhid.2009.023

  847

  PDF: 590

  HTML: 1451

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2590

  PDF: 1605

  HTML: 2354

  Table1: 188

• The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy

  Nawfal R Hussein

  e2017005

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.005

  1584

  PDF: 808

  HTML: 657

• HHVs AND LYMPHOPROLIFERATIVE DISORDERS

  C Quadrelli, P Barozzi, G Riva, Mario Luppi

  e2011043

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.043

  1379

  PDF: 814

  HTML: 3117

• NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis

  alvisa palese, chiara visintini, margherita venturini, gianpaolo gargiulo, stefano botti

  e2019051

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.051

  1846

  PDF: 1045

  HTML: 242

• In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

  Jochen J Frietsch, Detlef Michel, Thomas Stamminger, Friederike Hunstig, Sebastian Birndt, Ulf Schnetzke, Sebastian Scholl, Andreas Hochhaus, Inken Hilgendorf

  e2019001

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.001

  2312

  PDF: 1421

  HTML: 253

• IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia

  Maja Ružić, Natalija Rajić, Milotka Fabri, Ivana Urošević, Marina Dragičević Jojkić, Tomislav Preveden, Maria Pete, Nebojša Rajić

  e2021058

  2021-08-29

  https://doi.org/10.4084/MJHID.2021.058

  839

  PDF: 346

  HTML: 147

• ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

  Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed

  e2017026

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.026

  2487

  PDF: 890

  HTML: 1290

  Untitled: 221

• IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti

  e2016057

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.057

  4313

  PDF: 1098

  HTML: 1414

• the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

  Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci

  e2021061

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.061

  1187

  PDF: 400

  HTML: 196

• Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib : a case report and a review

  Domenico Santorsola, Elisabetta Abruzzese

  e2015020

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.020

  1998

  PDF: 1217

  HTML: 1623

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4079

  PDF: 1576

  HTML: 936

• CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

  Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori

  e2019048

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.048

  1921

  PDF: 1159

  HTML: 265

• IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop

  e2009010

  2009-11-13

  https://doi.org/10.4084/mjhid.2009.010

  1162

  PDF: 600

  HTML: 6797

• HEPATITIS C VIRUS INFECTION AND LYMPHOMA

  Emmanuel Bachy, Caroline Besson, Felipe Suarez, Olivier Hermine

  e2010004

  2010-03-25

  https://doi.org/10.4084/mjhid.2010.004

  990

  PDF: 532

  HTML: 7808

• MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

  Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi

  e2012032

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.032

  2683

  PDF: 1000

  HTML: 2265

• Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab

  Ruben Fernandez, Esther Gonzalez, Almudena Fernandez, Ana Pilar Gonzalez, Juan Manuel Sancho, Francisco Dominguez, Carmen Fernandez

  e2014017

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.017

  1599

  PDF: 879

  HTML: 3154

  Figure 5: 153

  Figure 4: 157

  Figure 3: 191

  Figure 1: 169

  Figure 2: 165

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1322

  PDF: 567

  HTML: 216

• Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B

  Jurgen Gerada, Elaine Borg, Denise Formosa, Rosalie Magro, James Pocock

  e2013035

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.035

  2108

  PDF: 815

  HTML: 1637

  Figure 1: 279

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  3859

  PDF: 1469

  HTML: 8510

• DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

  Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà

  e2018040

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.040

  3664

  PDF: 1281

  HTML: 725

  Figure 2: 449

  Figure 1: 3114

• THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

  Vincenzo De Sanctis

  e2016058

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.058

  4192

  PDF: 1185

  HTML: 1177

• LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

  Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis

  e2014025

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.025

  2215

  PDF: 2143

  HTML: 2428

• CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

  Laura Jorge, Diego Torres, Agustín Languasco, Pablo Rodriguez, Pablo Bonvehí, Elena Temporiti, Silvia Relloso, Cristina Videla, Fabián Herrera

  e2020025

  2020-05-01

  https://doi.org/10.4084/mjhid.2020.025

  8095

  PDF: 775

  HTML: 219

• ATYPICAL DERMATOLOGICAL MANIFESTATIONS OF SYPHILIS IN ADVANCED HIV: A CASE-BASED NARRATIVE REVIEW

  Irene Scarvaglieri, Federico Cesanelli, Giorgio Tiecco, Iacopo Ghini, Davide Minisci, Caterina Davoli, Stefano Rapino, Emanuele Focà, Maria Alberti, Martina Salvi, Francesco Castelli, Eugenia Quiros-Roldan

  e2025056

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.056

  1499

  PDF: 852

  HTML: 265

• IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES

  Emanuele Focà, Benedetta Fumarola

  e2022016

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.016

  966

  PDF: 611

  HTML: 222

• Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

  Lorenza Torti, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili

  e2012008

  2012-01-25

  https://doi.org/10.4084/mjhid.2012.008

  1830

  PDF: 828

  HTML: 1578

• IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

  Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor

  e2019063

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.063

  1325

  PDF: 747

  HTML: 210

• A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma

  Jonathan Braue, Thomas Hagele, Abraham Tareq Yacoub, Suganya Mannivanan, Frank Glass, Lubomir Sokol, John Norman Greene

  e2015026

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.026

  2193

  PDF: 941

  HTML: 5057

  Cover Letter: 167

  Figure 2: 159

  Figure 1: 172

  Figure 3: 193

  Figure 4: 165

  Figure Legend: 182

  Table 1: 185

  Table 2: 178

  Table 3: 177

• CLINICAL AND LABORATORY CHARACTERISTICS OF DENGUE-ORIENTI TSUTSUGAMUSHI CO-INFECTION FROM A TERTIARY CARE CENTER IN SOUTH INDIA

  Aneesh Basheer, Nayyar Iqbal, Sudhagar Mookkappan, Patricia Anitha, Shashikala Nair, Reba Kanungo, Ravichandran Kandasamy

  e2016028

  2016-06-16

  https://doi.org/10.4084/mjhid.2016.028

  4992

  PDF: 924

  HTML: 1510